About Gene List

PF3D7_0810800 (PPPK-DHPS)

Genome location: Pf3D7_08_v3:547,896..551,057(+)

Genome classification: Core

Function and Localization

Product Description: hydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase

SignalP Peptide: N/A

# Transmembrane Domains: 0

EC Numbers: 2.5.1.15 (Dihydropteroate synthase);2.7.6.3 (2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase)

Curated GO (PlasmoDB):

Type GO Term Name
Component GO:0005740 mitochondrial envelope
Component GO:0005634 nucleus
Function GO:0004156 dihydropteroate synthase activity
Process GO:0006761 dihydrofolate biosynthetic process
Process GO:0009410 response to xenobiotic stimulus
Process GO:0046654 tetrahydrofolate biosynthetic process

Expression by stage (LR - Le Roch et al., and MCA - Malaria Cell Atlas):

Stage LR class MCA mean MCA prop. zeros
Sporozoite not expressed N/A N/A
Ring expressed 0.41 0.83
Trophozoite expressed 1.08 0.49
Schizont expressed 0.09 0.95
Gametocyte not expressed 0.28 0.85

More info:

Resistome Mutations

Old (Pf3D7v3) Gene ID: PF3D7_0810800

Resistome Missense Mutations: None

Resistome Compounds with Missense Mutations: None

Resistome # Samples with Disruptive Mutations: 0 (0 missense, 0 "interesting" missense)

Essentiality (ABS)

Zhang Phenotype: Non - Mutable in CDS

MIS: 0.195 | MFS: -2.767 | #Insertions: 0

PlasmoGEM Phenotype: Essential (Pb ortholog: PBANKA_1426700)

  • Relative Growth Rate: 0.10 ± 0.04
  • Confidence: 1.00

RMgmDB ABS Phenotype: Different from wild type (Pb ortholog: PBANKA_1426700)

Modification: Mutated | RMgm-5042

More info: PhenoPlasm Link

Binding Evidence

AlphaFill Uniprot ID: Q8IAU3

"Best" AlphaFill ligand hit: PAB (4-aminobenzoic acid, Local RMSD=0.13) with 6DAY (Global RMSD=3.91)

BRENDA EC Inhibitors:

EC # Name EC Inhibitors
2.5.1.15 dihydropteroate synthase KClfolatedapsonWR99210dapsoneTrp-LysPteroateampicillincycloguanilsulfonamidesulfadoxinesulfamoxole...
2.7.6.3 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase AMPKCldapsonePteroatesulfadoxineGuanidine-HClsulfathiazolesulfamethazinesulfamethoxazolesulfadimethoxine8-mercaptoguaninesulfamonomethoxine...

Orthology to BindingDB Entries:

UniProt Protein Name Species Homology Source BindingDB Ligands
Q81VW8 Dihydropteroate synthase Bacillus anthracis OrthoMCL, OrthoMCL BLAST CHEMBL3827297CHEMBL3828532CHEMBL3828019CHEMBL3828161...

Orthology Information

Ortholog Group (OrthoMCL): OG6_103256

No human ortholog(s)

Protein Information

Protein Length: 706 | Molecular Weight (kDa): 83.374

UniProt ID(s): C0J3L7, C0J3L8, C0J3L9, C0J3M0, C0J3M1, C0J3M2, Q25704, Q25866, Q27738, Q27892, Q8IAU3

PDB ID(s): None

Isoelectric Point: 7.11

Protein Domain Annotations:

Source Family ID Description
InterPro IPR000489 Pterin-binding domain
InterPro IPR000550 7,8-Dihydro-6-hydroxymethylpterin-pyrophosphokinase, HPPK
InterPro IPR006390 Dihydropteroate synthase
InterPro IPR011005 Dihydropteroate synthase-like
InterPro IPR035907 7,8-Dihydro-6-hydroxymethylpterin-pyrophosphokinase HPPK superfamily
PFam PF00809 Pterin-binding domain
PFam PF01288 7,8-Dihydro-6-hydroxymethylpterin-pyrophosphokinase, HPPK
Superfamily SSF51717 Dihydropteroate synthase-like
Superfamily SSF55083 7,8-Dihydro-6-hydroxymethylpterin-pyrophosphokinase HPPK superfamily

Genetic Variation

MalariaGEN Pf7 (worldwide samples) # unique SNV/indels:

Homozygous genotype calls only

variant type common rare doubleton singleton
synonymous 4 4 7 8
disruptive 11 15 5 33
missense 11 14 4 25

Any inclusion in genotype call

variant type common rare doubleton singleton
synonymous 4 19 5 28
disruptive 18 39 40 129
missense 14 26 30 83

PlasmoDB Total SNPs: 123

Non-coding: 82 | Synonymous: 24 | Nonsynonymous: 17 | Stop Codon: 0

Associated Publications

PMID Title Authors DOI/Link
9391132 Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamideresistance in Plasmodium falciparum. Triglia T, Menting JG, Wilson C, Cowman AF 10.1073/pnas.94.25.13944
15279950 Molecular characterization of bifunctional hydroxymethyldihydropterinpyrophosphokinase-dihydropteroate synthase from Plasmodium falciparum. Kasekarn W, Sirawaraporn R, ..., Sirawaraporn W 10.1016/j.molbiopara.2004.04.012
15642967 Principal role of dihydropteroate synthase mutations in mediating resistance tosulfadoxine-pyrimethamine in single-drug and combination therapy of uncomplicatedmalaria in Uganda. Dorsey G, Dokomajilar C, ..., Rosenthal PJ https://pubmed.ncbi.nlm.nih.gov/15642967/
20890550 [Point mutations in dihydrofolate reductase and dihydropteroate synthase genes ofPlasmodium falciparum from three endemic malaria regions in Colombia]. Galindo JA, Cristiano FA, ..., Guerra AP https://pubmed.ncbi.nlm.nih.gov/20890550/
22909027 Novel quadruple mutations in dihydropteroate synthase genes of Plasmodiumfalciparum in West Bengal, India. Das S, Chakraborty SP, ..., Roy S 10.1111/j.1365-3156.2012.03071.x
23181666 Organellar proteomics reveals hundreds of novel nuclear proteins in the malariaparasite Plasmodium falciparum. Oehring SC, Woodcroft BJ, ..., Voss TS 10.1186/gb-2012-13-11-r108
24321120 Mutational analysis of Plasmodium falciparum dihydrofolate reductase anddihydropteroate synthase genes in the interior division of Sabah, Malaysia. Lau TY, Sylvi M, William T 10.1186/1475-2875-12-445
25187019 Two novel mutations of pfdhps K540T and I588F, affectingsulphadoxine-pyrimethamine-resistant response in uncomplicated falciparum malariaat Banjar district, South Kalimantan Province, Indonesia. Basuki S, Fitriah, ..., Uemura H 10.1186/1475-2875-13-135
25311473 Genetic mutations in Plasmodium falciparum and Plasmodium vivax dihydrofolatereductase (DHFR) and dihydropteroate synthase (DHPS) in Vanuatu and SolomonIslands prior to the introduction of artemisinin combination therapy. Gresty KJ, Gray KA, ..., Waters NC 10.1186/1475-2875-13-402
25943379 High prevalence of dhfr and dhps molecular markers in Plasmodium falciparum inpregnant women of Nchelenge district, Northern Zambia. Siame MN, Mharakurwa S, ..., Michelo C 10.1186/s12936-015-0676-5
28533179 Polymorphisms in pfdhfr and pfdhps genes after five years of artemisinincombination therapy (ACT) implementation from urban Kolkata, India. Chatterjee M, Ganguly S, ..., Maji AK 10.1016/j.meegid.2017.05.013
16517168 Elucidation of sulfadoxine resistance with structural models of the bifunctionalPlasmodium falciparum dihydropterin pyrophosphokinase-dihydropteroate synthase de Beer TA, Louw AI, Joubert F 10.1016/j.bmc.2006.02.035
36124481 In silico study to predict promiscuous T cell and B cell-epitopes derived fromthe vaccine candidate antigens of Plasmodium vivax binding to MHC class-IIalleles Khan N, Bin-Mwena MN, ..., Farooq U 10.4103/0972-9062.335726
12232841 Origin and dissemination of Plasmodium falciparum drug-resistance mutations inSouth America Cortese JF, Caraballo A, Contreras CE, Plowe CV 10.1086/342946
15866722 Purification, properties, and crystallization of Saccharomyces cerevisiaedihydropterin pyrophosphokinase-dihydropteroate synthase Berglez J, Pilling P, Macreadie I, Fernley RT 10.1016/j.pep.2005.02.003
19635897 Assessment of the origins and spread of putative resistance-conferring mutationsin Plasmodium vivax dihydropteroate synthase Hawkins VN, Suzuki SM, ..., Sibley CH https://pubmed.ncbi.nlm.nih.gov/19635897/
9661026 Molecular basis of in vivo resistance to sulfadoxine-pyrimethamine in Africanadult patients infected with Plasmodium falciparum malaria parasites Basco LK, Tahar R, Ringwald P 10.1128/AAC.42.7.1811
9178266 Isolation and molecular characterization of the bifunctionalhydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase gene fromToxoplasma gondii Pashley TV, Volpe F, ..., Delves CJ https://pubmed.ncbi.nlm.nih.gov/9178266/
12165384 Rapid positive selection of stable integrants following transfection ofPlasmodium falciparum Wang P, Wang Q, Sims PF, Hyde JE 10.1016/s0166-6851(02)00105-6